Guanine Inc is categorized under Microbiology and Virology Diagnostic Products in Salt Lake City, UT and active since 2012.
Guanine Inc was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Microbiology and Virology Diagnostic Products business, which does work in the B2B market, and is classified as a Microbiology and Virology Diagnostic Products, under code number 325412 by the NAICS.
If you are seeking more information, feel free to contact Bruce Gale at the company’s single location by writing to 825 North 300 West # C325, Salt Lake City, Utah UT 84103 or by phoning (801) 792-7074. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Guanine Inc |
| Contact Person: | Bruce Gale |
| Address: | 825 North 300 West # C325, Salt Lake City, Utah 84103 |
| Phone Number: | (801) 792-7074 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Microbiology and Virology Diagnostic Products |
| SIC Code: | 2835 |
| NAICS Code: | 325412 |
| Share This Business: |
Guanine Inc was started in 2012 to provide professional Microbiology and Virology Diagnostic Products under the SIC code 2835 and NAICS code 325412. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Bruce Gale for inquiries that concern Guanine Inc by calling the company number (801) 792-7074, as your correspondence is most welcome. Additionally, the physical location of the single location of Guanine Inc can be found at the coordinates 40.787291,-111.899877 as well as the street address 825 North 300 West # C325 in Salt Lake City, Utah 84103.
For its online presence, you may visit Guanine Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.